首页 > 最新文献

Human reproduction最新文献

英文 中文
Impacts of double biopsy and double vitrification on the clinical outcomes following euploid blastocyst transfer: a systematic review and meta-analysis 双活检和双玻璃化对优倍囊胚移植临床结果的影响:系统回顾和荟萃分析
IF 6.1 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-08 DOI: 10.1093/humrep/deae235
Kate Bickendorf, Fang Qi, Kelli Peirce, Rui Wang, Jay Natalwala, Vincent Chapple, Yanhe Liu
STUDY QUESTION Compared to the ‘single biopsy + single vitrification’ approach, do ‘double biopsy + double vitrification’ or ‘single biopsy + double vitrification’ arrangements compromise subsequent clinical outcomes following euploidy blastocyst transfer? SUMMARY ANSWER Both ‘double biopsy + double vitrification’ and ‘single biopsy + double vitrification’ led to reduced live birth/ongoing pregnancy rates and clinical pregnancy rates. WHAT IS KNOWN ALREADY? It is not uncommon to receive inconclusive results following blastocyst biopsy and preimplantation genetic testing for aneuploidy (PGT-A). Often these blastocysts are warmed for re-test after a second biopsy, experiencing ‘double biopsy + double vitrification’. Furthermore, to achieve better workflow, IVF laboratories may choose to routinely vitrify all blastocysts and schedule biopsy at a preferred timing, involving ‘single biopsy + double vitrification’. However, in the current literature, there is a lack of systematic evaluation of both arrangements regarding their potential clinical risks in reference to the most common ‘single biopsy + single vitrification’ approach. STUDY DESIGN, SIZE, DURATION A systematic review and meta-analysis were performed, with the protocol registered in PROSPERO (CRD42023469143). A search in PUBMED, EMBASE, and the Cochrane Library for relevant studies was carried out on 30 August 2023, using the keywords ‘biopsy’ and ‘vitrification’ and associated variations respectively. Only studies involving frozen transfers of PGT-A tested euploid blastocysts were included, with those involving PGT-M or PGT-SR excluded. PARTICIPANTS/MATERIALS, SETTING, METHODS Study groups included blastocysts having undergone ‘double biopsy + double vitrification’ or ‘single biopsy + double vitrification’, with a ‘single biopsy + single vitrification’ group used as control. The primary outcome was clinical pregnancy, while secondary outcomes included live birth/ongoing pregnancy, miscarriage, and post-warming survival rates. Random effects meta-analysis was performed with risk ratios (RR) and 95% CIs were used to present outcome comparisons. MAIN RESULTS AND THE ROLE OF CHANCE A total of 607 records were identified through the initial search and nine studies (six full articles and three abstracts) were eventually included. Compared to ‘single biopsy + single vitrification’, ‘double biopsy + double vitrification’ was associated with reduced clinical pregnancy rates (six studies, n = 18 754; RR = 0.80, 95% CI = 0.71–0.89; I2 = 0%) and live birth/ongoing pregnancy rates (seven studies, n = 20 964; RR = 0.72, 95% CI = 0.63–0.82; I2 = 0%). However, no significant changes were seen in miscarriage rates (seven studies, n = 22 332; RR = 1.40, 95% CI = 0.92–2.11; I2 = 53%) and post-warming survival rates (three studies, n = 13 562; RR = 1.00, 95% CI = 0.99–1.01; I2 = 0%) following ‘double biopsy + double vitrification’. Furthermore, ‘single biopsy + double vitrification’ was also linked with decrea
研究问题 与 "单活检+单玻璃化 "方法相比,"双活检+双玻璃化 "或 "单活检+双玻璃化 "安排是否会影响非整倍体囊胚移植后的临床结果?简答 "双活检+双玻璃化 "和 "单活检+双玻璃化 "都会降低活产率/持续妊娠率和临床妊娠率。已经知道了什么?囊胚活检和植入前非整倍体基因检测(PGT-A)结果不确定的情况并不少见。通常情况下,这些囊胚会在第二次活检后进行再次检测,即 "双重活检 + 双重玻璃化"。此外,为了实现更好的工作流程,IVF 实验室可能会选择对所有囊胚进行常规玻璃化处理,并在首选时间安排活检,即 "单次活检 + 双次玻璃化"。然而,与最常见的 "单次活检 + 单次玻璃化 "方法相比,目前的文献缺乏对这两种安排潜在临床风险的系统评估。研究设计、规模、持续时间 进行了系统性综述和荟萃分析,研究方案已在 PROSPERO(CRD42023469143)上注册。2023 年 8 月 30 日,分别使用关键词 "活检 "和 "玻璃化 "及相关变体在 PUBMED、EMBASE 和 Cochrane 图书馆搜索相关研究。只有涉及冷冻移植 PGT-A 检测过的单倍体囊胚的研究才被纳入,涉及 PGT-M 或 PGT-SR 的研究不包括在内。研究组包括经过 "双活检+双玻璃化 "或 "单活检+双玻璃化 "的囊胚,"单活检+单玻璃化 "组作为对照。主要结果是临床妊娠,次要结果包括活产/继续妊娠、流产和升温后存活率。随机效应荟萃分析采用风险比(RR)和95% CI来进行结果比较。主要结果和偶然性的作用 通过初步搜索共发现了 607 条记录,最终纳入了 9 项研究(6 篇全文和 3 篇摘要)。与 "单活检+单玻璃化 "相比,"双活检+双玻璃化 "与临床妊娠率降低(6 项研究,n = 18 754;RR = 0.80,95% CI = 0.71-0.89;I2 = 0%)和活产/持续妊娠率降低(7 项研究,n = 20 964;RR = 0.72,95% CI = 0.63-0.82;I2 = 0%)有关。然而,在 "双活检+双玻璃化 "后,流产率(7 项研究,n = 22 332;RR = 1.40,95% CI = 0.92-2.11;I2 = 53%)和升温后存活率(3 项研究,n = 13 562;RR = 1.00,95% CI = 0.99-1.01;I2 = 0%)没有明显变化。此外,"单活检+双玻璃化 "还与临床妊娠率下降(6 项研究,n = 13 284;RR = 0.84,95% CI = 0.76-0.92;I2 = 39%)和活产/持续妊娠率下降(7 项研究,n = 16 800;RR = 0.79,95% CI = 0.69-0.91;I2 = 70%)有关。91;I2 = 70%),流产率增加(5 项研究,n = 15 781;RR = 1.48,95% CI = 1.31-1.67;I2 = 0%),但 "单次活检 + 双次玻璃化 "不会影响取暖后存活率(3 项研究,n = 12 452;RR = 0.99,95% CI = 0.97-1.01;I2 = 71%)。局限性、注意事项 本荟萃分析所纳入的所有研究均为回顾性研究,不同结果存在不同程度的异质性。并非所有研究都考虑了潜在的混杂因素。只有一项研究报告了新生儿的结果。研究结果的广泛影响 我们的数据表明,"双活检+双玻璃化 "和 "单活检+双玻璃化 "对极倍体囊胚移植后的临床结果有不利影响。在向患者提供此类方法时,应仔细咨询其风险。活检过程应尽可能谨慎和称职,以减少诊断不明确的情况。研究经费/合作利益 R.W.获得了国家健康与医学研究委员会新兴领导研究者资助(2009767)。没有其他外部资金需要报告。所有作者均未报告利益冲突。注册号:CRD42023469143。
{"title":"Impacts of double biopsy and double vitrification on the clinical outcomes following euploid blastocyst transfer: a systematic review and meta-analysis","authors":"Kate Bickendorf, Fang Qi, Kelli Peirce, Rui Wang, Jay Natalwala, Vincent Chapple, Yanhe Liu","doi":"10.1093/humrep/deae235","DOIUrl":"https://doi.org/10.1093/humrep/deae235","url":null,"abstract":"STUDY QUESTION Compared to the ‘single biopsy + single vitrification’ approach, do ‘double biopsy + double vitrification’ or ‘single biopsy + double vitrification’ arrangements compromise subsequent clinical outcomes following euploidy blastocyst transfer? SUMMARY ANSWER Both ‘double biopsy + double vitrification’ and ‘single biopsy + double vitrification’ led to reduced live birth/ongoing pregnancy rates and clinical pregnancy rates. WHAT IS KNOWN ALREADY? It is not uncommon to receive inconclusive results following blastocyst biopsy and preimplantation genetic testing for aneuploidy (PGT-A). Often these blastocysts are warmed for re-test after a second biopsy, experiencing ‘double biopsy + double vitrification’. Furthermore, to achieve better workflow, IVF laboratories may choose to routinely vitrify all blastocysts and schedule biopsy at a preferred timing, involving ‘single biopsy + double vitrification’. However, in the current literature, there is a lack of systematic evaluation of both arrangements regarding their potential clinical risks in reference to the most common ‘single biopsy + single vitrification’ approach. STUDY DESIGN, SIZE, DURATION A systematic review and meta-analysis were performed, with the protocol registered in PROSPERO (CRD42023469143). A search in PUBMED, EMBASE, and the Cochrane Library for relevant studies was carried out on 30 August 2023, using the keywords ‘biopsy’ and ‘vitrification’ and associated variations respectively. Only studies involving frozen transfers of PGT-A tested euploid blastocysts were included, with those involving PGT-M or PGT-SR excluded. PARTICIPANTS/MATERIALS, SETTING, METHODS Study groups included blastocysts having undergone ‘double biopsy + double vitrification’ or ‘single biopsy + double vitrification’, with a ‘single biopsy + single vitrification’ group used as control. The primary outcome was clinical pregnancy, while secondary outcomes included live birth/ongoing pregnancy, miscarriage, and post-warming survival rates. Random effects meta-analysis was performed with risk ratios (RR) and 95% CIs were used to present outcome comparisons. MAIN RESULTS AND THE ROLE OF CHANCE A total of 607 records were identified through the initial search and nine studies (six full articles and three abstracts) were eventually included. Compared to ‘single biopsy + single vitrification’, ‘double biopsy + double vitrification’ was associated with reduced clinical pregnancy rates (six studies, n = 18 754; RR = 0.80, 95% CI = 0.71–0.89; I2 = 0%) and live birth/ongoing pregnancy rates (seven studies, n = 20 964; RR = 0.72, 95% CI = 0.63–0.82; I2 = 0%). However, no significant changes were seen in miscarriage rates (seven studies, n = 22 332; RR = 1.40, 95% CI = 0.92–2.11; I2 = 53%) and post-warming survival rates (three studies, n = 13 562; RR = 1.00, 95% CI = 0.99–1.01; I2 = 0%) following ‘double biopsy + double vitrification’. Furthermore, ‘single biopsy + double vitrification’ was also linked with decrea","PeriodicalId":13003,"journal":{"name":"Human reproduction","volume":null,"pages":null},"PeriodicalIF":6.1,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142385650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Female-age-dependent changes in the lipid fingerprint of the mammalian oocytes. 哺乳动物卵母细胞脂质指纹的变化与雌性年龄有关。
IF 6 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-04 DOI: 10.1093/humrep/deae225
Simona Bisogno, Joanna Depciuch, Hafsa Gulzar, Maria Florencia Heber, Michał Kobiałka, Łukasz Gąsior, Adrianna Bereta, Anna Pieczara, Kinga Fic, Richard Musson, Gabriel Garcia Gamero, Maria Pardo Martinez, Alba Fornés Pérez, Martina Tatíčková, Zuzana Holubcova, Małgorzata Barańska, Grażyna Ewa Ptak
<p><strong>Study question: </strong>Can oocyte functionality be assessed by observing changes in their intracytoplasmic lipid droplets (LDs) profiles?</p><p><strong>Summary answer: </strong>Lipid profile changes can reliably be detected in human oocytes; lipid changes are linked with maternal age and impaired developmental competence in a mouse model.</p><p><strong>What is known already: </strong>In all cellular components, lipid damage is the earliest manifestation of oxidative stress (OS), which leads to a cascade of negative consequences for organelles and DNA. Lipid damage is marked by the accumulation of LDs. We hypothesized that impaired oocyte functionality resulting from aging and associated OS could be assessed by changes in LDs profile, hereafter called lipid fingerprint (LF).</p><p><strong>Study design, size, duration: </strong>To investigate if it is possible to detect differences in oocyte LF, we subjected human GV-stage oocytes to spectroscopic examinations. For this, a total of 48 oocytes derived from 26 young healthy women (under 33 years of age) with no history of infertility, enrolled in an oocyte donation program, were analyzed. Furthermore, 30 GV human oocytes from 12 women were analyzed by transmission electron microscopy (TEM). To evaluate the effect of oocytes' lipid profile changes on embryo development, a total of 52 C57BL/6 wild-type mice and 125 Gnpat+/- mice were also used.</p><p><strong>Participants/materials, setting, methods: </strong>Human oocytes were assessed by label-free cell imaging via coherent anti-Stokes Raman spectroscopy (CARS). Further confirmation of LF changes was conducted using spontaneous Raman followed by Fourier transform infrared (FTIR) spectroscopies and TEM. Additionally, to evaluate whether LF changes are associated with developmental competence, mouse oocytes and blastocysts were evaluated using TEM and the lipid dyes BODIPY and Nile Red. Mouse embryonic exosomes were evaluated using flow cytometry, FTIR and FT-Raman spectroscopies.</p><p><strong>Main results and the role of chance: </strong>Here we demonstrated progressive changes in the LF of oocytes associated with the woman's age consisting of increased LDs size, area, and number. LF variations in oocytes were detectable also within individual donors. This finding makes LF assessment a promising tool to grade oocytes of the same patient, based on their quality. We next demonstrated age-associated changes in oocytes reflected by lipid peroxidation and composition changes; the accumulation of carotenoids; and alterations of structural properties of lipid bilayers. Finally, using a mouse model, we showed that LF changes in oocytes are negatively associated with the secretion of embryonic exosomes prior to implantation. Deficient exosome secretion disrupts communication between the embryo and the uterus and thus may explain recurrent implantation failures in advanced-age patients.</p><p><strong>Limitations, reasons for caution: </strong>Due t
研究问题:能否通过观察卵母细胞胞质内脂滴(LDs)的变化来评估卵母细胞的功能?在人类卵母细胞中可以可靠地检测到脂质轮廓的变化;在小鼠模型中,脂质变化与母体年龄和发育能力受损有关:在所有细胞成分中,脂质损伤是氧化应激(OS)的最早表现形式,氧化应激会对细胞器和DNA产生一系列负面影响。脂质损伤的标志是低密度脂蛋白的积累。我们假设,衰老和相关的OS导致的卵母细胞功能受损可通过LDs图谱(以下称为脂质指纹(LF))的变化来评估:为了研究是否有可能检测到卵母细胞脂质指纹的差异,我们对人类GV期卵母细胞进行了光谱检测。为此,我们分析了总共 48 个卵母细胞,这些卵母细胞来自 26 名无不孕史的年轻健康女性(33 岁以下),她们都参加了卵母细胞捐献计划。此外,还通过透射电子显微镜(TEM)分析了来自 12 名女性的 30 个 GV 人类卵母细胞。为了评估卵母细胞脂质分布变化对胚胎发育的影响,研究人员还使用了52只C57BL/6野生型小鼠和125只Gnpat+/-小鼠。使用自发拉曼光谱、傅立叶变换红外光谱(FTIR)和 TEM 进一步确认低频变化。此外,为了评估 LF 变化是否与发育能力有关,还使用 TEM 和脂质染料 BODIPY 和尼罗河红对小鼠卵母细胞和囊胚进行了评估。使用流式细胞术、傅立叶变换红外光谱和傅立叶变换拉曼光谱对小鼠胚胎外泌体进行了评估:在这里,我们证明了卵母细胞低频的渐进变化与女性的年龄有关,包括低频区大小、面积和数量的增加。在个体捐献者中也能检测到卵母细胞低密度的变化。这一发现使 LF 评估成为根据同一患者的卵母细胞质量对其进行分级的有效工具。接下来,我们通过脂质过氧化和成分变化、类胡萝卜素的积累以及脂质双层结构特性的改变,证明了卵母细胞与年龄相关的变化。最后,我们利用小鼠模型表明,卵母细胞中的 LF 变化与胚胎植入前的外泌体分泌呈负相关。外泌体分泌不足会破坏胚胎与子宫之间的交流,因此可能是高龄患者反复种植失败的原因:由于不同物种卵母细胞中脂质含量的差异,脂质氧化对哺乳动物卵母细胞发育的影响以及随之而来的LF变化可能有所不同:我们的发现为开发一种创新的卵母细胞评估工具提供了可能,并突出了卵母细胞低密度与胚胎外泌体分泌之间可能存在的功能性联系。通过认识卵母细胞低密度在塑造胚胎植入能力方面的作用,我们的原创性工作为发育生物学和生殖医学的未来研究方向指明了方向:本研究由波兰国家科学中心资助,资助金:2021/41/B/NZ3/03507和2019/35/B/NZ4/03547(给G.E.P.);2022/44/C/NZ4/00076(给M.F.H.)和2019/35/NZ3/03213(给Ł.G.)。M.F.H.是国家学术交流机构(NAWA)研究员(GA ULM/2019/1/00097/U/00001)。K.F.是钻石基金研究员(教育和科学部GA 0175/DIA/2019/28)。本文的公开发表得到了克拉科夫雅盖隆大学 "卓越倡议--研究型大学 "计划下的优先研究领域BioS的资助。作者声明不存在利益冲突:不适用。
{"title":"Female-age-dependent changes in the lipid fingerprint of the mammalian oocytes.","authors":"Simona Bisogno, Joanna Depciuch, Hafsa Gulzar, Maria Florencia Heber, Michał Kobiałka, Łukasz Gąsior, Adrianna Bereta, Anna Pieczara, Kinga Fic, Richard Musson, Gabriel Garcia Gamero, Maria Pardo Martinez, Alba Fornés Pérez, Martina Tatíčková, Zuzana Holubcova, Małgorzata Barańska, Grażyna Ewa Ptak","doi":"10.1093/humrep/deae225","DOIUrl":"10.1093/humrep/deae225","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Study question: &lt;/strong&gt;Can oocyte functionality be assessed by observing changes in their intracytoplasmic lipid droplets (LDs) profiles?&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Summary answer: &lt;/strong&gt;Lipid profile changes can reliably be detected in human oocytes; lipid changes are linked with maternal age and impaired developmental competence in a mouse model.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;What is known already: &lt;/strong&gt;In all cellular components, lipid damage is the earliest manifestation of oxidative stress (OS), which leads to a cascade of negative consequences for organelles and DNA. Lipid damage is marked by the accumulation of LDs. We hypothesized that impaired oocyte functionality resulting from aging and associated OS could be assessed by changes in LDs profile, hereafter called lipid fingerprint (LF).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Study design, size, duration: &lt;/strong&gt;To investigate if it is possible to detect differences in oocyte LF, we subjected human GV-stage oocytes to spectroscopic examinations. For this, a total of 48 oocytes derived from 26 young healthy women (under 33 years of age) with no history of infertility, enrolled in an oocyte donation program, were analyzed. Furthermore, 30 GV human oocytes from 12 women were analyzed by transmission electron microscopy (TEM). To evaluate the effect of oocytes' lipid profile changes on embryo development, a total of 52 C57BL/6 wild-type mice and 125 Gnpat+/- mice were also used.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Participants/materials, setting, methods: &lt;/strong&gt;Human oocytes were assessed by label-free cell imaging via coherent anti-Stokes Raman spectroscopy (CARS). Further confirmation of LF changes was conducted using spontaneous Raman followed by Fourier transform infrared (FTIR) spectroscopies and TEM. Additionally, to evaluate whether LF changes are associated with developmental competence, mouse oocytes and blastocysts were evaluated using TEM and the lipid dyes BODIPY and Nile Red. Mouse embryonic exosomes were evaluated using flow cytometry, FTIR and FT-Raman spectroscopies.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main results and the role of chance: &lt;/strong&gt;Here we demonstrated progressive changes in the LF of oocytes associated with the woman's age consisting of increased LDs size, area, and number. LF variations in oocytes were detectable also within individual donors. This finding makes LF assessment a promising tool to grade oocytes of the same patient, based on their quality. We next demonstrated age-associated changes in oocytes reflected by lipid peroxidation and composition changes; the accumulation of carotenoids; and alterations of structural properties of lipid bilayers. Finally, using a mouse model, we showed that LF changes in oocytes are negatively associated with the secretion of embryonic exosomes prior to implantation. Deficient exosome secretion disrupts communication between the embryo and the uterus and thus may explain recurrent implantation failures in advanced-age patients.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Limitations, reasons for caution: &lt;/strong&gt;Due t","PeriodicalId":13003,"journal":{"name":"Human reproduction","volume":null,"pages":null},"PeriodicalIF":6.0,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142375326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
24-hour movement behaviours and cardiometabolic markers in women with polycystic ovary syndrome (PCOS): a compositional data analysis. 多囊卵巢综合征(PCOS)妇女的 24 小时运动行为和心脏代谢指标:组成数据分析。
IF 6 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-04 DOI: 10.1093/humrep/deae232
E Pesonen, V Farrahi, C J Brakenridge, M M Ollila, L C Morin-Papunen, M Nurkkala, T Jämsä, R Korpelainen, L J Moran, T T Piltonen, M Niemelä
<p><strong>Study question: </strong>Are 24-h movement composition and time reallocations between the movement behaviours (moderate-to-vigorous physical activity (MVPA), light physical activity (LPA), sedentary behaviour (SB), and sleep) differentially associated with cardiometabolic markers in women with polycystic ovary syndrome (PCOS) relative to women without PCOS?</p><p><strong>Summary answer: </strong>There was no difference in 24-h movement composition between the groups, although among women without PCOS, reducing SB time while increasing either MVPA or LPA time was associated with beneficial differences in cardiometabolic markers, whereas in women with PCOS beneficial differences were observed only when SB time was replaced with MVPA.</p><p><strong>What is known already: </strong>Women with PCOS display lower levels of physical activity, higher sedentary time, and less total sleep than women without the syndrome. Exercise interventions among women with PCOS have shown improvements in body composition and insulin sensitivity, while the findings regarding blood pressure, insulin resistance, and lipid profiles are contradictory.</p><p><strong>Study design, size, duration: </strong>This study was part of a prospective, general population-based Northern Finland Birth Cohort 1966 (NFBC1966) (n = 5889 women). At the 31-year and 46-year follow-up, data collection was performed through postal and clinical examinations, including fasting blood samples and anthropometric measurements. Accelerometer data collection of 14 days (n = 2602 women) and a 2-h oral glucose tolerance test (n = 2780 women) were performed at the 46-year follow-up. Participants were identified as women with or without PCOS at age 31 (n = 1883), and the final study population included those who provided valid accelerometer data at age 46 (n = 857).</p><p><strong>Participants/materials, setting, methods: </strong>Women with PCOS (n = 192) were identified based on the 2023 International Evidence-based Guideline, while those who exhibited no PCOS features were considered women without PCOS (controls; n = 665). Accelerometer-measured MVPA, LPA, and SB were combined with self-reported sleep to obtain 24-h compositions. Multivariable regression analysis based on compositional data analysis and isotemporal reallocations were performed to investigate the associations between 24-h movement composition and cardiometabolic markers. Isotemporal reallocations were expressed as differences (%Δ) from the sample's mean.</p><p><strong>Main results and the role of chance: </strong>There was no difference in overall 24-h movement composition between women with PCOS and controls in midlife. The 24-h movement composition was associated with waist circumference, triglycerides, fasting serum insulin, and Homeostatic Model Assessment-insulin resistance (HOMA-IR) in both controls and women with PCOS. Reallocating 15 min from SB to MVPA was associated with favourable differences in cardiometabolic markers
申报了 Gedeon Richter、Organon、Astellas、Roche 的咨询费;Gedeon Richter、Exeltis、Roche、Stragen、Merck、Organon 的演讲费;以及 Gedeon Richter 的差旅资助。其余作者声明无利益冲突:不适用。
{"title":"24-hour movement behaviours and cardiometabolic markers in women with polycystic ovary syndrome (PCOS): a compositional data analysis.","authors":"E Pesonen, V Farrahi, C J Brakenridge, M M Ollila, L C Morin-Papunen, M Nurkkala, T Jämsä, R Korpelainen, L J Moran, T T Piltonen, M Niemelä","doi":"10.1093/humrep/deae232","DOIUrl":"10.1093/humrep/deae232","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Study question: &lt;/strong&gt;Are 24-h movement composition and time reallocations between the movement behaviours (moderate-to-vigorous physical activity (MVPA), light physical activity (LPA), sedentary behaviour (SB), and sleep) differentially associated with cardiometabolic markers in women with polycystic ovary syndrome (PCOS) relative to women without PCOS?&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Summary answer: &lt;/strong&gt;There was no difference in 24-h movement composition between the groups, although among women without PCOS, reducing SB time while increasing either MVPA or LPA time was associated with beneficial differences in cardiometabolic markers, whereas in women with PCOS beneficial differences were observed only when SB time was replaced with MVPA.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;What is known already: &lt;/strong&gt;Women with PCOS display lower levels of physical activity, higher sedentary time, and less total sleep than women without the syndrome. Exercise interventions among women with PCOS have shown improvements in body composition and insulin sensitivity, while the findings regarding blood pressure, insulin resistance, and lipid profiles are contradictory.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Study design, size, duration: &lt;/strong&gt;This study was part of a prospective, general population-based Northern Finland Birth Cohort 1966 (NFBC1966) (n = 5889 women). At the 31-year and 46-year follow-up, data collection was performed through postal and clinical examinations, including fasting blood samples and anthropometric measurements. Accelerometer data collection of 14 days (n = 2602 women) and a 2-h oral glucose tolerance test (n = 2780 women) were performed at the 46-year follow-up. Participants were identified as women with or without PCOS at age 31 (n = 1883), and the final study population included those who provided valid accelerometer data at age 46 (n = 857).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Participants/materials, setting, methods: &lt;/strong&gt;Women with PCOS (n = 192) were identified based on the 2023 International Evidence-based Guideline, while those who exhibited no PCOS features were considered women without PCOS (controls; n = 665). Accelerometer-measured MVPA, LPA, and SB were combined with self-reported sleep to obtain 24-h compositions. Multivariable regression analysis based on compositional data analysis and isotemporal reallocations were performed to investigate the associations between 24-h movement composition and cardiometabolic markers. Isotemporal reallocations were expressed as differences (%Δ) from the sample's mean.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main results and the role of chance: &lt;/strong&gt;There was no difference in overall 24-h movement composition between women with PCOS and controls in midlife. The 24-h movement composition was associated with waist circumference, triglycerides, fasting serum insulin, and Homeostatic Model Assessment-insulin resistance (HOMA-IR) in both controls and women with PCOS. Reallocating 15 min from SB to MVPA was associated with favourable differences in cardiometabolic markers","PeriodicalId":13003,"journal":{"name":"Human reproduction","volume":null,"pages":null},"PeriodicalIF":6.0,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142375324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early menstrual cycle impacts of oestrogen and progesterone on the timing of the fertile window. 月经周期早期雌激素和孕激素对受孕窗口时间的影响。
IF 6 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-04 DOI: 10.1093/humrep/deae236
René Ecochard, Thomas Bouchard, Rene Leiva, Saman H Abdullah, Hans Boehringer
<p><strong>Study question: </strong>What is the effect of oestrogen and progesterone at the beginning of the menstrual cycle in delaying entry into the fertile window?</p><p><strong>Summary answer: </strong>Both oestrogen and progesterone contribute to a delay in the onset of the fertile window.</p><p><strong>What is known already: </strong>Oestrogen enhances cervical mucus secretion while progesterone inhibits it.</p><p><strong>Study design, size, duration: </strong>Observational study. Daily observation of 220 menstrual cycles contributed by 88 women with no known menstrual cycle disorder.</p><p><strong>Participants/materials, setting, methods: </strong>Women recorded cervical mucus daily and collected first-morning urine samples for analysis of oestrone-3-glucuronide, pregnanediol-3-alpha-glucuronide (PDG), FHS, and LH. They underwent serial ovarian ultrasound examinations. The main outcome measure was the timing within the cycle of the onset of the fertile window, as identified by the appearance of mucus felt or seen at the vulva.</p><p><strong>Main results and the role of chance: </strong>Low oestrogen secretion and persistent progesterone secretion during the first week of the menstrual cycle both negatively affect mucus secretion. Doubling oestrogen approximately doubled the odds of entering the fertile window (OR: 1.82 95% CI=1.23; 2.69). Increasing PDG from below 1.5 to 4 µg/mg creatinine was associated with a 2-fold decrease in the odds of entering the fertile window (OR: 0.51 95% CI=0.31; 0.82). Prolonged progesterone secretion during the first week of the menstrual cycle was also statistically significantly associated with higher LH secretion. Finally, the later onset of the fertile window was associated with statistically significant persistently elevated LH secretion during the luteal phase of the previous menstrual cycle.</p><p><strong>Limitations, reasons for caution: </strong>This post hoc study was conducted to assess the potential impact of residual progesterone secretion at the beginning of the menstrual cycle. It was conducted on an existing data set because of the scarcity of data available to answer the question. Analysis with other datasets with similar hormone results would be useful to confirm these findings.</p><p><strong>Wider implications of the findings: </strong>This study provides evidence for residual progesterone secretion in the early latency phase of some menstrual cycles, which may delay the onset of the fertile window. This progesterone secretion may be supported by subtly increased LH secretion during the few days before and after the onset of menses, which may relate to follicular waves in the luteal phase. Persistent progesterone secretion should be considered in predicting the onset of the fertile window and in assessing ovulatory dysfunction.</p><p><strong>Study funding/competing interest(s): </strong>The authors declare no conflicts of interest. No funding was provided for this secondary data analysis.<
研究问题:月经周期开始时的雌激素和孕激素对推迟进入可孕窗口期有何影响?雌激素和孕酮都有助于推迟受孕窗口期的到来:研究设计、规模、持续时间:观察研究。对 88 名未发现月经周期紊乱的妇女所贡献的 220 个月经周期进行每日观察:妇女每天记录宫颈粘液并收集清晨尿液样本,用于分析雌酮-3-葡萄糖醛酸、孕二醇-3-α-葡萄糖醛酸(PDG)、FHS 和 LH。她们接受了连续的卵巢超声波检查。主要结果是通过外阴感觉到或看到粘液的出现来确定受孕窗开始的周期时间:主要结果和偶然性的作用:月经周期第一周雌激素分泌过少和孕酮分泌持续过多都会对粘液分泌产生负面影响。雌激素增加一倍,进入受孕窗口期的几率大约增加一倍(OR:1.82 95% CI=1.23;2.69)。将 PDG 从低于 1.5 微克/毫克肌酐提高到 4 微克/毫克肌酐与进入受孕窗的几率降低 2 倍相关(OR:0.51 95% CI=0.31; 0.82)。在统计学上,月经周期第一周孕酮分泌延长与 LH 分泌增加也有显著相关性。最后,可孕窗口期开始较晚与前一个月经周期黄体期 LH 分泌持续升高有明显的统计学关联:这项事后研究旨在评估月经周期开始时残余孕酮分泌的潜在影响。由于可用于回答该问题的数据较少,因此该研究是在现有数据集上进行的。与其他具有类似激素结果的数据集进行分析将有助于证实这些发现:这项研究为某些月经周期的早期潜伏期残留孕酮分泌提供了证据,这可能会推迟受孕窗口期的到来。在月经来潮前后的几天里,LH 的分泌量会有微妙的增加,这可能与黄体期的卵泡波有关。在预测受孕窗口期的开始和评估排卵功能障碍时,应考虑持续的孕酮分泌:作者声明无利益冲突。本次二次数据分析未获得任何资助:不适用。
{"title":"Early menstrual cycle impacts of oestrogen and progesterone on the timing of the fertile window.","authors":"René Ecochard, Thomas Bouchard, Rene Leiva, Saman H Abdullah, Hans Boehringer","doi":"10.1093/humrep/deae236","DOIUrl":"10.1093/humrep/deae236","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Study question: &lt;/strong&gt;What is the effect of oestrogen and progesterone at the beginning of the menstrual cycle in delaying entry into the fertile window?&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Summary answer: &lt;/strong&gt;Both oestrogen and progesterone contribute to a delay in the onset of the fertile window.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;What is known already: &lt;/strong&gt;Oestrogen enhances cervical mucus secretion while progesterone inhibits it.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Study design, size, duration: &lt;/strong&gt;Observational study. Daily observation of 220 menstrual cycles contributed by 88 women with no known menstrual cycle disorder.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Participants/materials, setting, methods: &lt;/strong&gt;Women recorded cervical mucus daily and collected first-morning urine samples for analysis of oestrone-3-glucuronide, pregnanediol-3-alpha-glucuronide (PDG), FHS, and LH. They underwent serial ovarian ultrasound examinations. The main outcome measure was the timing within the cycle of the onset of the fertile window, as identified by the appearance of mucus felt or seen at the vulva.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main results and the role of chance: &lt;/strong&gt;Low oestrogen secretion and persistent progesterone secretion during the first week of the menstrual cycle both negatively affect mucus secretion. Doubling oestrogen approximately doubled the odds of entering the fertile window (OR: 1.82 95% CI=1.23; 2.69). Increasing PDG from below 1.5 to 4 µg/mg creatinine was associated with a 2-fold decrease in the odds of entering the fertile window (OR: 0.51 95% CI=0.31; 0.82). Prolonged progesterone secretion during the first week of the menstrual cycle was also statistically significantly associated with higher LH secretion. Finally, the later onset of the fertile window was associated with statistically significant persistently elevated LH secretion during the luteal phase of the previous menstrual cycle.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Limitations, reasons for caution: &lt;/strong&gt;This post hoc study was conducted to assess the potential impact of residual progesterone secretion at the beginning of the menstrual cycle. It was conducted on an existing data set because of the scarcity of data available to answer the question. Analysis with other datasets with similar hormone results would be useful to confirm these findings.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Wider implications of the findings: &lt;/strong&gt;This study provides evidence for residual progesterone secretion in the early latency phase of some menstrual cycles, which may delay the onset of the fertile window. This progesterone secretion may be supported by subtly increased LH secretion during the few days before and after the onset of menses, which may relate to follicular waves in the luteal phase. Persistent progesterone secretion should be considered in predicting the onset of the fertile window and in assessing ovulatory dysfunction.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Study funding/competing interest(s): &lt;/strong&gt;The authors declare no conflicts of interest. No funding was provided for this secondary data analysis.&lt;","PeriodicalId":13003,"journal":{"name":"Human reproduction","volume":null,"pages":null},"PeriodicalIF":6.0,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142375325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paternal age, de novo mutations, and offspring health? New directions for an ageing problem. 父亲年龄、新基因突变与后代健康?老龄化问题的新方向
IF 6 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-03 DOI: 10.1093/humrep/deae230
Robert John Aitken

This Directions article examines the mechanisms by which a father's age impacts the health and wellbeing of his children. Such impacts are significant and include adverse birth outcomes, dominant genetic conditions, neuropsychiatric disorders, and a variety of congenital developmental defects. As well as age, a wide variety of environmental and lifestyle factors are also known to impact offspring health via changes mediated by the male germ line. This picture of a dynamic germ line responsive to a wide range of intrinsic and extrinsic factors contrasts with the results of trio studies indicating that the incidence of mutations in the male germ line is low and exhibits a linear, monotonic increase with paternal age (∼two new mutations per year). While the traditional explanation for this pattern of mutation has been the metronomic plod of replication errors, an alternative model pivots around the 'faulty male' hypothesis. According to this concept, the genetic integrity of the male germ line can be dynamically impacted by age and a variety of other factors, and it is the aberrant repair of such damage that drives mutagenesis. Fortunately, DNA proofreading during spermatogenesis is extremely effective and these mutant cells are either repaired or deleted by apoptosis/ferroptosis. There appear to be only two mechanisms by which mutant germ cells can escape this apoptotic fate: (i) if the germ cells acquire a mutation that by enhancing proliferation or suppressing apoptosis, permits their clonal expansion (selfish selection hypothesis) or (ii) if a genetically damaged spermatozoon manages to fertilize an oocyte, which then fixes the damage as a mutation (or epimutation) as a result of defective DNA repair (oocyte collusion hypothesis). Exploration of these proposed mechanisms should not only help us better understand the aetiology of paternal age effects but also inform potential avenues of remediation.

这篇方向性文章探讨了父亲的年龄对其子女的健康和幸福产生影响的机制。这些影响是巨大的,包括不利的出生结果、显性遗传病、神经精神障碍和各种先天性发育缺陷。除年龄外,各种环境和生活方式因素也会通过男性生殖系介导的变化影响后代的健康。男性生殖系对各种内在和外在因素的反应是动态的,这与三组研究结果形成了鲜明对比,三组研究结果表明,男性生殖系的突变发生率很低,并且随着父亲年龄的增长而呈线性、单调增长(每年发生两次新的突变)。对这种突变模式的传统解释是复制错误的节拍性蹒跚,而另一种模式则围绕着 "有问题的雄性 "假说。根据这一概念,男性生殖系的遗传完整性会受到年龄和其他各种因素的动态影响,而正是这种损伤的异常修复导致了突变。幸运的是,精子发生过程中的DNA校对非常有效,这些突变细胞要么得到修复,要么被细胞凋亡/铁蛋白沉积所删除。突变的生殖细胞似乎只有两种机制可以逃脱凋亡的命运:(i)如果生殖细胞获得了一种突变,这种突变通过增强增殖或抑制凋亡而允许其克隆扩增(自私选择假说),或(ii)如果基因受损的精子设法使卵母细胞受精,然后卵母细胞由于缺陷的DNA修复而将损伤固定为突变(或表突变)(卵母细胞串通假说)。对这些假说机制的探索不仅有助于我们更好地理解父系年龄效应的病因,还能为潜在的补救途径提供信息。
{"title":"Paternal age, de novo mutations, and offspring health? New directions for an ageing problem.","authors":"Robert John Aitken","doi":"10.1093/humrep/deae230","DOIUrl":"https://doi.org/10.1093/humrep/deae230","url":null,"abstract":"<p><p>This Directions article examines the mechanisms by which a father's age impacts the health and wellbeing of his children. Such impacts are significant and include adverse birth outcomes, dominant genetic conditions, neuropsychiatric disorders, and a variety of congenital developmental defects. As well as age, a wide variety of environmental and lifestyle factors are also known to impact offspring health via changes mediated by the male germ line. This picture of a dynamic germ line responsive to a wide range of intrinsic and extrinsic factors contrasts with the results of trio studies indicating that the incidence of mutations in the male germ line is low and exhibits a linear, monotonic increase with paternal age (∼two new mutations per year). While the traditional explanation for this pattern of mutation has been the metronomic plod of replication errors, an alternative model pivots around the 'faulty male' hypothesis. According to this concept, the genetic integrity of the male germ line can be dynamically impacted by age and a variety of other factors, and it is the aberrant repair of such damage that drives mutagenesis. Fortunately, DNA proofreading during spermatogenesis is extremely effective and these mutant cells are either repaired or deleted by apoptosis/ferroptosis. There appear to be only two mechanisms by which mutant germ cells can escape this apoptotic fate: (i) if the germ cells acquire a mutation that by enhancing proliferation or suppressing apoptosis, permits their clonal expansion (selfish selection hypothesis) or (ii) if a genetically damaged spermatozoon manages to fertilize an oocyte, which then fixes the damage as a mutation (or epimutation) as a result of defective DNA repair (oocyte collusion hypothesis). Exploration of these proposed mechanisms should not only help us better understand the aetiology of paternal age effects but also inform potential avenues of remediation.</p>","PeriodicalId":13003,"journal":{"name":"Human reproduction","volume":null,"pages":null},"PeriodicalIF":6.0,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142371735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role, benefits, and risks of AMH testing for non-ART related indications. 针对非抗逆转录病毒药物相关适应症进行 AMH 检测的作用、益处和风险。
IF 6 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-03 DOI: 10.1093/humrep/deae234
Zoya Enakshi Ali, Claudia Massarotti, George Liperis, Mina Mincheva, Omar F Ammar, Julia Uraji, Antonio La Marca, Raj Mathur, Helen C O'Neill, Mariana Moura-Ramos, Juan J Fraire-Zamora
{"title":"Role, benefits, and risks of AMH testing for non-ART related indications.","authors":"Zoya Enakshi Ali, Claudia Massarotti, George Liperis, Mina Mincheva, Omar F Ammar, Julia Uraji, Antonio La Marca, Raj Mathur, Helen C O'Neill, Mariana Moura-Ramos, Juan J Fraire-Zamora","doi":"10.1093/humrep/deae234","DOIUrl":"https://doi.org/10.1093/humrep/deae234","url":null,"abstract":"","PeriodicalId":13003,"journal":{"name":"Human reproduction","volume":null,"pages":null},"PeriodicalIF":6.0,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142371736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protective effects of engineered Lactobacillus crispatus strains expressing G-CSF on thin endometrium of mice. 表达 G-CSF 的脆片乳杆菌工程菌株对小鼠薄子宫内膜的保护作用。
IF 6 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-01 DOI: 10.1093/humrep/deae190
Shuang Liu, Yingnan Zhang, Xin Ma, Chenglin Zhan, Ning Ding, Mai Shi, Wei Zhang, Shubao Yang
<p><strong>Study question: </strong>Does recombinant Lactobacillus expressing granulocyte colony-stimulating factor (G-CSF) have a better protective effect than the current treatment of thin endometrium (TE)?</p><p><strong>Summary answer: </strong>This study suggested that the intrauterine injection of Lactobacillus crispastus (L. crispastus)-pPG612-G-CSF has a positive effect on preventing TE induced by 95% alcohol in mice.</p><p><strong>What is known already: </strong>TE has a negative impact on the success rate of ART in patients, and is usually caused by intrauterine surgery, endometrial infection, or hormone drugs. Exogenous G-CSF can promote endometrial vascular remodelling and increase endometrial receptivity and the embryo implantation rate. Moreover, Lactobacillus plays a crucial role in maintaining and regulating the local microecological balance of the reproductive tract, and it could be a delivery carrier of the endometrial repair drug G-CSF.</p><p><strong>Study design, size, duration: </strong>We constructed engineered L. crispastus strains expressing G-CSF. The mice were divided into five groups: (i) Control group (C, n = 28), uteri were treated with preheated saline solution via intrauterine injection on the third and sixth day of oestrus; (ii) Model group (M, n = 35), where uteri were treated with 95% alcohol on the third day of oestrus and preheated saline solution on the sixth day of oestrus via intrauterine injection; (iii) L. crispatus-pPG612-treatment group (L, n = 45), where uteri were treated with 95% alcohol on the third day of oestrus and 0.1 ml × 108 CFU/ml L. crispatus-pPG612 on the sixth day of oestrus via intrauterine injection; (iv) L. crispatus-pPG612-treatment group (LG, n = 45), where uteri were treated with 95% alcohol on the third day of oestrus and 0.1 ml × 108 CFU/ml L. crispatus-pPG612-G-CSF on the sixth day of oestrus via intrauterine injection; (v) G-CSF-treatment group (G, n = 52), where uteri were treated with 95% alcohol on the third day of oestrus and 30 µg/kg G-CSF on the sixth day of oestrus via intrauterine injection. Then, we compared the effects of L. crispastus, L. crispatus-pPG612-G-CSF and G-CSF on endometrial thickness, angiogenesis, fibrosis, and inflammation in the TE mouse.</p><p><strong>Participants/materials, setting, methods: </strong>We collected uterine tissues for haematoxylin-eosin staining, immunohistochemical staining, Western blot and RT-PCR, as well as serum for ELISA and uterine flushing solution for high-throughput sequencing.</p><p><strong>Main results and the role of chance: </strong>Compared with those in the M group (the mice of the group were intrauterine injected 95% alcohol and treated with saline solution), the L. crispatus-pPG612-G-CSF strain increased the thickness of the endometrium (P < 0.001) and the number of blood vessels and glands (both P < 0.001), enhanced the expression of cytokeratin 19 (CK19) (P < 0.001), vimentin (Vim) (P < 0.001), vascular endothelial grow
研究问题:表达粒细胞集落刺激因子(G-CSF)的重组乳杆菌是否比目前治疗子宫内膜薄(TE)的方法具有更好的保护作用?本研究表明,宫腔内注射脆化乳杆菌(L. crispastus)-pPG612-G-CSF对预防95%酒精诱导的小鼠TE有积极作用:TE对患者抗逆转录病毒疗法的成功率有负面影响,通常由宫腔内手术、子宫内膜感染或激素药物引起。外源性 G-CSF 可促进子宫内膜血管重塑,提高子宫内膜接受性和胚胎着床率。此外,乳酸杆菌在维持和调节生殖道局部微生态平衡方面发挥着重要作用,可作为子宫内膜修复药物 G-CSF 的输送载体:研究设计、规模、持续时间:我们构建了表达G-CSF的L. crispastus工程菌株。小鼠分为五组:(i) 对照组(C,n = 28),在发情第三天和第六天通过宫腔注射预热生理盐水处理子宫;(ii) 模型组(M,n = 35),在发情第三天用 95% 酒精处理子宫,在发情第六天通过宫腔注射预热生理盐水处理子宫;(iii) L. crispatus-pPG612-t 组,在发情第三天用 95% 酒精处理子宫,在发情第六天通过宫腔注射预热生理盐水处理子宫。pPG612处理组(L,n = 45),发情第三天用95%酒精处理子宫,发情第六天宫内注射0.1 ml × 108 CFU/ml L. crispatus-pPG612 通过宫内注射;(iv) L. crispatus-pPG612 处理组(LG,n = 45),发情第三天用 95% 的酒精处理子宫,发情第六天用 0.1 ml × 108 CFU/ml L. crispatus-pPG612-G 处理子宫。(v) G-CSF 处理组(G,n = 52),发情第三天用 95% 酒精处理子宫,发情第六天宫内注射 30 µg/kg G-CSF。然后,我们比较了L. crispastus、L. crispatus-pPG612-G-CSF和G-CSF对TE小鼠子宫内膜厚度、血管生成、纤维化和炎症的影响:我们采集了子宫组织进行血栓素-伊红染色、免疫组化染色、Western blot和RT-PCR,还采集了血清进行ELISA和子宫冲洗液进行高通量测序:与 M 组(该组小鼠宫内注射 95% 酒精并用生理盐水处理)相比,L. crispatus-pPG612-G-CSF 菌株增加了子宫内膜厚度(P 大比例尺数据):不适用:L.crispatus-pPG612-G-CSF菌株疗法在加速TE的修复过程方面具有巨大潜力。然而,我们仅报告了与PI3K/AKT通路相关的基因和蛋白的表达,L. crispatus-pPG612-G-CSF对子宫内膜的修复可能还涉及许多其他机制:该研究结果为 TE 的治疗提供了新思路和新方法:本研究得到了吉林省科技发展计划项目(批准号:20210101232JC)、吉林省教育厅科技计划项目(批准号:JT53101022010)和吉林医科大学博士科研启动基金(批准号:JYBS2021014LK和2022JYBS006KJ)的资助。作者声明,研究过程中不存在任何可能被视为潜在利益冲突的商业或经济关系。
{"title":"Protective effects of engineered Lactobacillus crispatus strains expressing G-CSF on thin endometrium of mice.","authors":"Shuang Liu, Yingnan Zhang, Xin Ma, Chenglin Zhan, Ning Ding, Mai Shi, Wei Zhang, Shubao Yang","doi":"10.1093/humrep/deae190","DOIUrl":"10.1093/humrep/deae190","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Study question: &lt;/strong&gt;Does recombinant Lactobacillus expressing granulocyte colony-stimulating factor (G-CSF) have a better protective effect than the current treatment of thin endometrium (TE)?&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Summary answer: &lt;/strong&gt;This study suggested that the intrauterine injection of Lactobacillus crispastus (L. crispastus)-pPG612-G-CSF has a positive effect on preventing TE induced by 95% alcohol in mice.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;What is known already: &lt;/strong&gt;TE has a negative impact on the success rate of ART in patients, and is usually caused by intrauterine surgery, endometrial infection, or hormone drugs. Exogenous G-CSF can promote endometrial vascular remodelling and increase endometrial receptivity and the embryo implantation rate. Moreover, Lactobacillus plays a crucial role in maintaining and regulating the local microecological balance of the reproductive tract, and it could be a delivery carrier of the endometrial repair drug G-CSF.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Study design, size, duration: &lt;/strong&gt;We constructed engineered L. crispastus strains expressing G-CSF. The mice were divided into five groups: (i) Control group (C, n = 28), uteri were treated with preheated saline solution via intrauterine injection on the third and sixth day of oestrus; (ii) Model group (M, n = 35), where uteri were treated with 95% alcohol on the third day of oestrus and preheated saline solution on the sixth day of oestrus via intrauterine injection; (iii) L. crispatus-pPG612-treatment group (L, n = 45), where uteri were treated with 95% alcohol on the third day of oestrus and 0.1 ml × 108 CFU/ml L. crispatus-pPG612 on the sixth day of oestrus via intrauterine injection; (iv) L. crispatus-pPG612-treatment group (LG, n = 45), where uteri were treated with 95% alcohol on the third day of oestrus and 0.1 ml × 108 CFU/ml L. crispatus-pPG612-G-CSF on the sixth day of oestrus via intrauterine injection; (v) G-CSF-treatment group (G, n = 52), where uteri were treated with 95% alcohol on the third day of oestrus and 30 µg/kg G-CSF on the sixth day of oestrus via intrauterine injection. Then, we compared the effects of L. crispastus, L. crispatus-pPG612-G-CSF and G-CSF on endometrial thickness, angiogenesis, fibrosis, and inflammation in the TE mouse.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Participants/materials, setting, methods: &lt;/strong&gt;We collected uterine tissues for haematoxylin-eosin staining, immunohistochemical staining, Western blot and RT-PCR, as well as serum for ELISA and uterine flushing solution for high-throughput sequencing.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main results and the role of chance: &lt;/strong&gt;Compared with those in the M group (the mice of the group were intrauterine injected 95% alcohol and treated with saline solution), the L. crispatus-pPG612-G-CSF strain increased the thickness of the endometrium (P &lt; 0.001) and the number of blood vessels and glands (both P &lt; 0.001), enhanced the expression of cytokeratin 19 (CK19) (P &lt; 0.001), vimentin (Vim) (P &lt; 0.001), vascular endothelial grow","PeriodicalId":13003,"journal":{"name":"Human reproduction","volume":null,"pages":null},"PeriodicalIF":6.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142043926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of embryologist stress, somatization, and burnout reported by embryologists working in UK HFEA-licensed ART/IVF clinics and USA ART/IVF clinics. 比较在英国 HFEA 许可的 ART/IVF 诊所和美国 ART/IVF 诊所工作的胚胎学家报告的胚胎学家压力、躯体化和职业倦怠情况。
IF 6 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-01 DOI: 10.1093/humrep/deae191
Anar Murphy, Mark S Lapczynski, Glenn Proctor, Timothy R Glynn, Alice D Domar, Sofia Gameiro, Giles A Palmer, Michael G Collins
<p><strong>Study question: </strong>What is the prevalence of occupational stress, somatization, and burnout reported by UK and US, embryologists and the impact of work conditions on these well-being outcomes?</p><p><strong>Summary answer: </strong>Surveyed UK and US embryologists reported moderate perceived stress, low somatic symptom severity, high levels of burnout, and overall stressful work conditions, but with differences that could be due to country-specific occupational and employment characteristics.</p><p><strong>What is known already?: </strong>Spanish, UK, US, and international surveys have identified high levels of occupational stress, somatization, burnout, and occupational health issues among embryologists. These issues have been attributed to embryologists' occupational challenges and work conditions.</p><p><strong>Study design, size, duration: </strong>A cross-sectional web-based survey was sent to 253 embryologists working in UK ART/IVF clinics and 487 embryologists working in US ART/IVF clinics.</p><p><strong>Participants/materials, setting, methods: </strong>Participants self-reported their stress levels, somatization, burnout, and work conditions. Proportions across the Perceived Stress Scale (PSS), Patient Health Questionnaire (PHQ-15), Maslach Burnout Inventory-General Survey (MBI-GS), a single-item work unit grade (A-F), and customized occupational and sociodemographic questionnaires were calculated using descriptive statistics. Welch's t-test was utilized to compare PSS and PHQ-15 scores between groups. Risk ratios were calculated using log-binomial regression for all models except for levels of anxiety related to performing cryostorage tasks, for which Poisson models were used.</p><p><strong>Main results and the role of chance: </strong>In total, 50.6% (128) of the embryologists in the UK and 50.1% (244) in the US completed the survey. Both groups self-reported moderate PSS and low PHQ-15 scores, although fewer UK embryologists scored high on the MBI cynicism dimension than their US colleagues (43% UK vs 60% US embryologists, P < 0.05). The UK and US embryologists did not differ on the MBI exhaustion dimension with both scoring high for exhaustion (59% UK vs 62% US). Although 81% and 80% of UK and US embryologists, respectively, reported working overtime, more embryologists in the UK reported being adequately compensated. Increasing levels of anxiety-related to cryostorage showed a dose-dependent increased risk of burnout on at least two MBI-GS dimensions only in the UK group, and, a dose-dependent likelihood of higher PSS and PHQ-15 scores in both groups.</p><p><strong>Limitations, reasons for caution: </strong>Since the two groups were surveyed 9 months apart and were self-reporting, the study is limited by the differences in responsibilities, scheduling, and workload specific to the time of year.</p><p><strong>Wider implications of the findings: </strong>Work-related health issues and occupational challenges shared by
研究问题:英国和美国胚胎学家报告的职业压力、躯体化和职业倦怠的发生率如何,以及工作条件对这些幸福结果的影响?接受调查的英国和美国胚胎学家报告了中等程度的感知压力、较低的躯体症状严重性、较高水平的职业倦怠和总体压力较大的工作条件,但可能因国家特定的职业和就业特点而存在差异:西班牙、英国、美国和国际调查发现,胚胎学家的职业压力、躯体化、职业倦怠和职业健康问题都很严重。这些问题归因于胚胎学家的职业挑战和工作条件:对在英国 ART/IVF 诊所工作的 253 名胚胎学家和在美国 ART/IVF 诊所工作的 487 名胚胎学家进行了横断面网络调查:参与者自我报告了他们的压力水平、躯体化、职业倦怠和工作条件。采用描述性统计方法计算了感知压力量表(PSS)、患者健康问卷(PHQ-15)、马斯拉赫职业倦怠调查表(MBI-GS)、单项工作单位等级(A-F)以及定制的职业和社会人口问卷的比例。采用韦尔奇 t 检验比较不同组间的 PSS 和 PHQ-15 分数。除与执行低温贮藏任务相关的焦虑水平采用泊松模型外,所有模型均采用对数二项式回归法计算风险比:共有 50.6% 的英国胚胎学家(128 人)和 50.1% 的美国胚胎学家(244 人)完成了调查。两组胚胎学家均自称PSS评分中等,PHQ-15评分较低,但在MBI愤世嫉俗维度上得分较高的英国胚胎学家少于美国同行(43%的英国胚胎学家对60%的美国胚胎学家,P 限制、谨慎的原因):由于两组人的调查时间相隔 9 个月,而且都是自我报告,因此研究受到了一年中特定时间的责任、日程安排和工作量差异的限制:研究结果的广泛意义:英国和美国胚胎学家共同面临的与工作相关的健康问题和职业挑战可以通过组织改进和技术来解决。英国胚胎学家的压力和倦怠程度较低,可能是由于HFEA提供的结构/确定性:该公司正在开发胚胎学自动化平台并将其商业化。M.G.C. 和 M.S.L. 是 TMRW 生命科学公司的全职员工和股东,Novavax 公司的 A.M. 是 TMRW 生命科学公司的员工。G.P. 是 TMRW 生命科学公司的顾问。其余作者声明无利益冲突:NCT05326802;NCT05708963。
{"title":"Comparison of embryologist stress, somatization, and burnout reported by embryologists working in UK HFEA-licensed ART/IVF clinics and USA ART/IVF clinics.","authors":"Anar Murphy, Mark S Lapczynski, Glenn Proctor, Timothy R Glynn, Alice D Domar, Sofia Gameiro, Giles A Palmer, Michael G Collins","doi":"10.1093/humrep/deae191","DOIUrl":"10.1093/humrep/deae191","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Study question: &lt;/strong&gt;What is the prevalence of occupational stress, somatization, and burnout reported by UK and US, embryologists and the impact of work conditions on these well-being outcomes?&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Summary answer: &lt;/strong&gt;Surveyed UK and US embryologists reported moderate perceived stress, low somatic symptom severity, high levels of burnout, and overall stressful work conditions, but with differences that could be due to country-specific occupational and employment characteristics.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;What is known already?: &lt;/strong&gt;Spanish, UK, US, and international surveys have identified high levels of occupational stress, somatization, burnout, and occupational health issues among embryologists. These issues have been attributed to embryologists' occupational challenges and work conditions.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Study design, size, duration: &lt;/strong&gt;A cross-sectional web-based survey was sent to 253 embryologists working in UK ART/IVF clinics and 487 embryologists working in US ART/IVF clinics.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Participants/materials, setting, methods: &lt;/strong&gt;Participants self-reported their stress levels, somatization, burnout, and work conditions. Proportions across the Perceived Stress Scale (PSS), Patient Health Questionnaire (PHQ-15), Maslach Burnout Inventory-General Survey (MBI-GS), a single-item work unit grade (A-F), and customized occupational and sociodemographic questionnaires were calculated using descriptive statistics. Welch's t-test was utilized to compare PSS and PHQ-15 scores between groups. Risk ratios were calculated using log-binomial regression for all models except for levels of anxiety related to performing cryostorage tasks, for which Poisson models were used.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main results and the role of chance: &lt;/strong&gt;In total, 50.6% (128) of the embryologists in the UK and 50.1% (244) in the US completed the survey. Both groups self-reported moderate PSS and low PHQ-15 scores, although fewer UK embryologists scored high on the MBI cynicism dimension than their US colleagues (43% UK vs 60% US embryologists, P &lt; 0.05). The UK and US embryologists did not differ on the MBI exhaustion dimension with both scoring high for exhaustion (59% UK vs 62% US). Although 81% and 80% of UK and US embryologists, respectively, reported working overtime, more embryologists in the UK reported being adequately compensated. Increasing levels of anxiety-related to cryostorage showed a dose-dependent increased risk of burnout on at least two MBI-GS dimensions only in the UK group, and, a dose-dependent likelihood of higher PSS and PHQ-15 scores in both groups.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Limitations, reasons for caution: &lt;/strong&gt;Since the two groups were surveyed 9 months apart and were self-reporting, the study is limited by the differences in responsibilities, scheduling, and workload specific to the time of year.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Wider implications of the findings: &lt;/strong&gt;Work-related health issues and occupational challenges shared by","PeriodicalId":13003,"journal":{"name":"Human reproduction","volume":null,"pages":null},"PeriodicalIF":6.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11447060/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142092811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply: Doppler ultrasound and first trimester pregnancy: not always a happy marriage. 回复:多普勒超声和怀孕头三个月:并不总是幸福的婚姻。
IF 6 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-01 DOI: 10.1093/humrep/deae177
E S de Vos, A G M G J Mulders, A H J Koning, S P Willemsen, M Rousian, B B van Rijn, E A P Steegers, R P M Steegers-Theunissen
{"title":"Reply: Doppler ultrasound and first trimester pregnancy: not always a happy marriage.","authors":"E S de Vos, A G M G J Mulders, A H J Koning, S P Willemsen, M Rousian, B B van Rijn, E A P Steegers, R P M Steegers-Theunissen","doi":"10.1093/humrep/deae177","DOIUrl":"10.1093/humrep/deae177","url":null,"abstract":"","PeriodicalId":13003,"journal":{"name":"Human reproduction","volume":null,"pages":null},"PeriodicalIF":6.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142046617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimized personalized management approach for moderate/severe OHSS: development and prospective validation of an OHSS risk assessment index. 中度/重度OHSS的优化个性化管理方法:OHSS风险评估指数的开发和前瞻性验证。
IF 6 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-01 DOI: 10.1093/humrep/deae197
Mingzhu Cao, Qiwang Lin, Zhi Liu, Yanshan Lin, Qing Huang, Yang Fu, Yang Zhang, Hang Shi, Chongyang Duan, Haiying Liu, Jianqiao Liu
<p><strong>Study question: </strong>Can a simplified ovarian hyperstimulation syndrome (OHSS) risk assessment index be developed and validated with sufficient discrimination of moderate/severe OHSS from those without OHSS?</p><p><strong>Summary answer: </strong>This easy-to-use OHSS risk assessment index shows good discriminative power and high calibration accuracy in internal and external validation cohorts.</p><p><strong>What is known already: </strong>An early alert and risk stratification is critical to prevent the occurrence of OHSS. We have previously developed a multi-stage smartphone app-based prediction model to evaluate the risk of OHSS, but app use might not be so convenient in many primary institutions. A simplified OHSS risk assessment index has been required.</p><p><strong>Study design, size, duration: </strong>This training and internal validation of an OHSS risk assessment index used retrospective cohort data from January 2016 to December 2020. External validation was performed with a prospective cohort database from January 2021 to May 2022. There were 15 066 cycles in the training cohort, 6502 cycles in the internal validation cohort, and 8097 cycles in the external validation cohort.</p><p><strong>Participants/materials, setting, methods: </strong>This study was performed in the reproductive medicine center of a tertiary hospital. Infertile women who underwent ovarian stimulation were included. Data were extracted from the local database with detailed medical records. A multi-stage risk assessment index was constructed at multiple stages. The first stage was before the initiation of ovarian stimulation, the second was before the ovulation trigger, the third was after oocyte retrieval, and the last stage was on the embryo transfer day if fresh embryo transfer was scheduled.</p><p><strong>Main results and the role of chance: </strong>We established a simplified multi-stage risk assessment index for moderate/severe OHSS, the performance of which was further evaluated with discrimination and calibration abilities in training and internal and external validation cohorts. The discrimination abilities of the OHSS risk assessment index were determined with C-statistics. C-statistics in training (Stages 1-4: 0.631, 0.692, 0.751, 0.788, respectively) and internal (Stages 1-4: 0.626, 0.642, 0.755, 0.771, respectively) and external validation (Stages 1-4: 0.668, 0.670, 0.754, 0.773, respectively) cohorts were all increased from Stage 1 to 3 with similar trends, and were comparable between Stages 3 and 4. Calibration plots showed high agreement between observed and predicted cases in all three cohorts. Incidences of OHSS based on diverse risk stratification (negligible risk, low risk, medium risk, and high risk) were 0%, 0.6%, 2.7%, and 8.3% in the training cohort, 0%, 0.6%, 3.3%, and 8.5% in the internal validation cohort, and 0.1%, 1.1%, 4.1%, and 7.2% in the external validation cohort.</p><p><strong>Limitations, reasons for caution: </st
研究问题:能否开发并验证一种简化的卵巢过度刺激综合征(OHSS)风险评估指数,以充分区分中度/重度OHSS和无OHSS患者?这一易于使用的卵巢过度刺激综合征风险评估指数在内部和外部验证队列中显示出良好的鉴别力和较高的校准准确性:早期预警和风险分层对于预防 OHSS 的发生至关重要。我们之前开发了一个基于智能手机应用程序的多阶段预测模型来评估OHSS风险,但在许多基层医疗机构,使用应用程序可能并不那么方便。我们需要一个简化的OHSS风险评估指标:本次OHSS风险评估指数的培训和内部验证使用了2016年1月至2020年12月的回顾性队列数据。外部验证使用的是 2021 年 1 月至 2022 年 5 月的前瞻性队列数据库。培训队列中有 15 066 个周期,内部验证队列中有 6502 个周期,外部验证队列中有 8097 个周期:本研究在一家三甲医院的生殖医学中心进行。研究对象包括接受卵巢刺激的不孕妇女。数据来自当地数据库的详细医疗记录。在多个阶段构建了多阶段风险评估指数。第一阶段为卵巢刺激开始前,第二阶段为排卵触发前,第三阶段为取卵后,最后一个阶段为胚胎移植日(如果安排了鲜胚移植):我们建立了一个简化的中度/重度OHSS多阶段风险评估指标,并通过训练队列、内部和外部验证队列的判别和校准能力对该指标的性能进行了进一步评估。OHSS风险评估指数的判别能力由C统计量决定。训练队列(第 1-4 阶段:分别为 0.631、0.692、0.751、0.788)和内部验证队列(第 1-4 阶段:分别为 0.626、0.642、0.755、0.771)及外部验证队列(第 1-4 阶段:分别为 0.668、0.670、0.754、0.773)的 C 统计量从第 1 阶段到第 3 阶段均呈上升趋势,且第 3 阶段和第 4 阶段之间的趋势相似。校准图显示,在所有三个队列中,观察病例与预测病例之间的一致性很高。根据不同的风险分层(可忽略风险、低风险、中风险和高风险),OHSS 的发生率在训练队列中分别为 0%、0.6%、2.7% 和 8.3%,在内部验证队列中分别为 0%、0.6%、3.3% 和 8.5%,在外部验证队列中分别为 0.1%、1.1%、4.1% 和 7.2%:不能排除临床干预(包括冷冻保存所有胚胎)的影响,因此某些风险因素(如触发日的雌激素水平)可能会被赋予较低的风险评分。该研究的另一个不足之处是,模型中没有记录和评估几种预防性治疗,如口服阿司匹林和来曲唑。尽管OHSS评估指数非常可靠,但该工具不能直接用于临床决策或作为诊断工具。它的价值在于能够评估各种干预措施的预后,并促进临床医生与患者之间的沟通。应将这一工具与进一步的症状和检查结合起来考虑,以便对 OHSS 进行准确和个性化的管理:研究结果的广泛意义:OHSS风险评估指数可用于促进OHSS的个性化咨询和管理:本研究得到了国家重点研发计划(2022YFC2702504)、广东省医学科研基金(A2024003)和广东省支援新疆农村科技(特派员)计划(KTPYJ 2023014)的支持。所有作者均未披露任何信息:不详。
{"title":"Optimized personalized management approach for moderate/severe OHSS: development and prospective validation of an OHSS risk assessment index.","authors":"Mingzhu Cao, Qiwang Lin, Zhi Liu, Yanshan Lin, Qing Huang, Yang Fu, Yang Zhang, Hang Shi, Chongyang Duan, Haiying Liu, Jianqiao Liu","doi":"10.1093/humrep/deae197","DOIUrl":"10.1093/humrep/deae197","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Study question: &lt;/strong&gt;Can a simplified ovarian hyperstimulation syndrome (OHSS) risk assessment index be developed and validated with sufficient discrimination of moderate/severe OHSS from those without OHSS?&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Summary answer: &lt;/strong&gt;This easy-to-use OHSS risk assessment index shows good discriminative power and high calibration accuracy in internal and external validation cohorts.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;What is known already: &lt;/strong&gt;An early alert and risk stratification is critical to prevent the occurrence of OHSS. We have previously developed a multi-stage smartphone app-based prediction model to evaluate the risk of OHSS, but app use might not be so convenient in many primary institutions. A simplified OHSS risk assessment index has been required.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Study design, size, duration: &lt;/strong&gt;This training and internal validation of an OHSS risk assessment index used retrospective cohort data from January 2016 to December 2020. External validation was performed with a prospective cohort database from January 2021 to May 2022. There were 15 066 cycles in the training cohort, 6502 cycles in the internal validation cohort, and 8097 cycles in the external validation cohort.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Participants/materials, setting, methods: &lt;/strong&gt;This study was performed in the reproductive medicine center of a tertiary hospital. Infertile women who underwent ovarian stimulation were included. Data were extracted from the local database with detailed medical records. A multi-stage risk assessment index was constructed at multiple stages. The first stage was before the initiation of ovarian stimulation, the second was before the ovulation trigger, the third was after oocyte retrieval, and the last stage was on the embryo transfer day if fresh embryo transfer was scheduled.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main results and the role of chance: &lt;/strong&gt;We established a simplified multi-stage risk assessment index for moderate/severe OHSS, the performance of which was further evaluated with discrimination and calibration abilities in training and internal and external validation cohorts. The discrimination abilities of the OHSS risk assessment index were determined with C-statistics. C-statistics in training (Stages 1-4: 0.631, 0.692, 0.751, 0.788, respectively) and internal (Stages 1-4: 0.626, 0.642, 0.755, 0.771, respectively) and external validation (Stages 1-4: 0.668, 0.670, 0.754, 0.773, respectively) cohorts were all increased from Stage 1 to 3 with similar trends, and were comparable between Stages 3 and 4. Calibration plots showed high agreement between observed and predicted cases in all three cohorts. Incidences of OHSS based on diverse risk stratification (negligible risk, low risk, medium risk, and high risk) were 0%, 0.6%, 2.7%, and 8.3% in the training cohort, 0%, 0.6%, 3.3%, and 8.5% in the internal validation cohort, and 0.1%, 1.1%, 4.1%, and 7.2% in the external validation cohort.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Limitations, reasons for caution: &lt;/st","PeriodicalId":13003,"journal":{"name":"Human reproduction","volume":null,"pages":null},"PeriodicalIF":6.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142139891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Human reproduction
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1